Remicade
Infusion-based anti-TNF therapy for severe, rapidly progressive disease.
Remicade (infliximab) is given by intravenous infusion, delivering anti-TNF therapy with the speed that severe disease demands. In dermatology it may be considered for selected severe or treatment-resistant inflammatory disease; some uses are off-label and require specialist assessment.
- Infusion
- Route
- 6–8 weekly
- Interval
- 2–6 wks
- First results
- TNF-alpha
- Target
- Weight-based dosing
- Induction infusions
- Supervised administration
- Immunomodulator co-therapy
Diagnosed first, treated second.
Infusions are supervised in clinic with observation throughout. Dosing is weight-based and individualized. Concomitant medicines and infusion intervals are selected by the specialist, balancing response, infusion reactions, infection risk and antibody formation.
- 01Weight-based dosing
- 02Induction infusions
- 03Supervised administration
- 04Immunomodulator co-therapy
- 05Infection surveillance
- Severe or rapidly worsening disease
- Failure of injectable biologics
- Generalised pustular or erythrodermic flares
- Severe hidradenitis with extensive tunnelling
- Able to attend supervised infusions
How the treatment works
A sequence, not a single appointment — each step informs the next.
- 01
Selection
Severity, speed of progression and prior therapy determine whether infusion is the right route.
- 02
Screening
Tuberculosis and hepatitis screening, cardiac history and baseline bloodwork.
- 03
Induction infusions
Weeks zero, two and six, each supervised with observation for reaction.
- 04
Maintenance
Infusions every six to eight weeks, with interval and dose set by response.
Results measured, not promised.
What to expect
- 01Potentially rapid control in selected severe disease
- 02May be considered for selected severe pustular disease
- 03Reduced inflammation in severe hidradenitis
- 04Improvement in psoriatic joint disease
- 05Clinic-supervised, closely monitored dosing
Results, treatment timing and recovery vary by diagnosis and individual factors. This page is educational and does not replace a medical consultation or guarantee an outcome. Prescription treatment is selected after reviewing current product information, approved indications, infection and vaccination history, other medicines and drug-specific risks.
Begin with a diagnosis,
not a guess.
Share a few details and the clinic will reply with available consultation times for remicade — one-to-one with Dr. Arely.
- Response
- Within 24 hours
- Consultation
- One-to-one, 45 min
- Assessment
- Trichoscopy included
- Location
- Dr. Arely Clinic
Frequently asked
Around two hours, with a period of observation afterwards during the early doses.
It delivers higher, weight-adjusted dosing quickly — valuable when disease is severe or progressing fast.
Infusion reactions can occur. Remicade also carries boxed warnings for serious infections and malignancies, so screening and ongoing specialist monitoring are required.
It can be. Interval and dose are adjusted, and de-escalation is considered once disease is stable.